State Street’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

State Street’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-2,468,665	Closed	-$59.5M	–	3724
2014 Q2	$59.5M	Sell	2,468,665 -1,805,530	-42%	-$18.8M	0.01%	1146
2014 Q1	$25.8M	Buy	4,274,195 +256,605	+6%	+$1.79M	﹤0.01%	1584
2013 Q4	$24M	Buy	4,017,590 +621,596	+18%	+$2.88M	﹤0.01%	1616
2013 Q3	$17.7M	Buy	3,395,994 +704,573	+26%	+$3.09M	﹤0.01%	1778
2013 Q2	$9.71M	Buy	+2,691,421	New	+$11M	﹤0.01%	2062

State Street's IDIX Position: Q3 2014 in Review

State Street sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 2,468,665 shares — an estimated $59.5M sold.

State Street first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $59.5M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

State Street reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
State Street sold 2,468,665 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $59.5M.
State Street first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
State Street's IDENIX PHARMACEUTICALS INC position peaked at $59.5M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on State Street's 13F filing for Q3 2014, filed 10 Nov 2014.